Despite Price Caps, Indian Pharmaceutical Sales Recover

After dipping this past fall after the implementation of the New Pharma Pricing Policy (NPPP), the overall volume growth has started to rebound. Read more. (Source: Business Standard, 1/19/14).

You might also be interested in:

The Global Use of Medicine in 2019 and Outlook to 2023 January 29, 2019
AP Report: Drug Prices Move Higher Despite Trump's Promise September 25, 2018
Health Affairs Blog Post Touts Reference Pricing June 10, 2019
Pfizer CEO: Business as Normal Come January October 31, 2018
ICER Using New Economic Modeling Platform for Value Assessment August 24, 2018
PRMA Consulting Offers Highlights of Meeting with Pricing Experts July 27, 2018
Azar: New York Times Misleading Public on Administration's… July 24, 2018